Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katrine Verena Wirgenes"'
Autor:
Aleksandra Ratajska, Magnus D. Vigeland, Katrine Verena Wirgenes, Kirsten Krohg‐Sørensen, Benedicte Paus
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 11, Iss 2, Pp n/a-n/a (2023)
Abstract Background While representing a significant improvement, the introduction of next‐generation sequencing in genetic diagnosis also prompted new challenges. Despite widely recognized consensus guidelines for the interpretation of sequence va
Externí odkaz:
https://doaj.org/article/4460c96c848448c6991841e18f5a2de6
Autor:
Maren Caroline Frogner Werner, Katrine Verena Wirgenes, Alexey Shadrin, Synve Hoffart Lunding, Linn Rødevand, Gabriela Hjell, Monica Bettina Elkjær Greenwood Ormerod, Marit Haram, Ingrid Agartz, Srdjan Djurovic, Ingrid Melle, Pål Aukrust, Thor Ueland, Ole Andreas Andreassen, Nils Eiel Steen
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Several lines of evidence implicate immune abnormalities in the pathophysiology of severe mental disorders (SMD) and comorbid mental disorders. Here, we use the data from genome-wide association studies (GWAS) of autoimmune diseases and ment
Externí odkaz:
https://doaj.org/article/0f3b79e2e3dc4c31a4f3897b7b496d86
Autor:
Aleksandra Ratajska, Magnus D. Vigeland, Katrine Verena Wirgenes, Kirsten Krohg‐Sørensen, Benedicte Paus
Publikováno v:
Molecular geneticsgenomic medicineREFERENCES.
Background While representing a significant improvement, the introduction of next-generation sequencing in genetic diagnosis also prompted new challenges. Despite widely recognized consensus guidelines for the interpretation of sequence variants, man
Autor:
Alyssa L. Ritter, Jessica Gold, Hiroshi Hayashi, Amanda M. Ackermann, Stephanie Hanke, Cara Skraban, Sanmati Cuddapah, Elizabeth Bhoj, Dong Li, Yukiko Kuroda, Jessica Wen, Ryojun Takeda, Audrey Bibb, Salima El Chehadeh, Amélie Piton, Jeanine Ohl, Mary K. Kukolich, Keisuke Nagasaki, Kohji Kato, Tomoo Ogi, Tricia Bhatti, Pierre Russo, Bryan Krock, Jill R. Murrell, Jennifer A. Sullivan, Vandana Shashi, Nicholas Stong, Hakon Hakonarson, Kentaro Sawano, Erin Torti, Rebecca Willaert, Yue Si, William Ross Wilcox, Katrine Verena Wirgenes, Kristian Thomassen, Katherine Carlotti, Angelika Erwin, Joanna Lazier, Thorsten Marquardt, Miao He, Andrew C. Edmondson, Kosuke Izumi
Publikováno v:
Genet Med
PURPOSE: This study aimed to describe the phenotypic and molecular characteristics of ARCN1-related syndrome. METHODS: Patients with ARCN1 variants were identified, and clinician researchers were connected using GeneMatcher and physician referrals. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86f4d63eea8ccc80eff372d25a1e057
https://europepmc.org/articles/PMC9923403/
https://europepmc.org/articles/PMC9923403/
Autor:
Maren Caroline Frogner Werner, Katrine Verena Wirgenes, Alexey A. Shadrin, Synve Hoffart Lunding, Linn Rødevand, Gabriela Hjell, Monica Bettina Elkjaer Greenwood Ormerod, Marit Haram, Ingrid Agartz, Srdjan Djurovic, Ingrid Melle, Pål Aukrust, Thor Ueland, Ole Andreas Andreassen, Nils Eiel Steen
Publikováno v:
Progress in Neuro-psychopharmacology and Biological Psychiatry
Background Low-grade inflammation may be part of the underlying mechanism of schizophrenia and bipolar disorder. We investigated if genetic susceptibility, infections or autoimmunity could explain the immune activation. Methods Seven immune markers w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf999fc6710821b5721182d2fa551e1
https://hdl.handle.net/11250/3009975
https://hdl.handle.net/11250/3009975
Autor:
Tesli M; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Wirgenes KV; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Hughes T; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Bettella F; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Athanasiu L; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Hoseth ES; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Nerhus M; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Lagerberg TV; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Steen NE; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Agartz I; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Melle I; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Dieset I; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Djurovic S; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ, Andreassen OA; Martin Tesli, MD, PhD, Katrine Verena Wirgenes, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Timothy Hughes, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Francesco Bettella, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Eva S. Hoseth, MD, Mari Nerhus, MD, Trine V. Lagerberg, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Nils E. Steen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Drammen District Psychiatric Centre, Clinic of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, Ingrid Dieset, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Univ
Publikováno v:
The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2016 Aug; Vol. 209 (2), pp. 114-20. Date of Electronic Publication: 2016 Mar 03.
Autor:
Wirgenes KV; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Tesli M; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Inderhaug E; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Athanasiu L; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Agartz I; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Melle I; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Hughes T; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Andreassen OA; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Djurovic S; Katrine Verena Wirgenes, MD, Martin Tesli, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Elin Inderhaug, BSc, Lavinia Athanasiu, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health & Addiction and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Ingrid Agartz, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital; and Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Ingrid Melle, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Timothy Hughes, PhD, Department of Medical Genetics, Oslo University Hospital; Ole Andreas Andreassen, MD, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo University Hospital; Srdjan Djurovic, PhD, NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, and Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Publikováno v:
The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2014 Sep; Vol. 205 (3), pp. 244-5. Date of Electronic Publication: 2014 May 08.